Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
6 pending office actions • 4 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
Jiangsu Hengrui Pharmaceuticals Co. Ltd. is active in Biotechnology & Pharmaceuticals with 6 pending office actions. These actions are distributed across 4 distinct art units. This suggests that the company's pharmaceutical technology spans several different technical areas, requiring a multi-faceted prosecution strategy.
The portfolio involves 6 distinct examiners. KOSACK, JOSEPH R is the busiest, with 1 pending office action. With 6 different examiners for the 6 pending actions, the company must navigate a variety of examiner styles across its applications. This distribution indicates that the company's patent success is spread across many independent reviews rather than being concentrated under one official.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (17%) |
| §112 only | 2 (33%) |
| Double-patenting + other | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSACK, JOSEPH R | 1 | 74.8% | -6.2% |
| RICCI, CRAIG D | 1 | 53.5% | +52.7% |
| SAMALA, JAGADISHWAR RAO | 1 | 68.0% | +55.6% |
| TCHERKASSKAYA, OLGA V | 1 | 55.4% | +46.2% |
| DEKARSKE, MADELINE MCGUIRE | 1 | 0.0% | +0.0% |
| HADDAD, MAHER M | 1 | 50.4% | +53.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18546071 | SMTP-7 DERIVATIVE AND USE THEREOF | DEKARSKE, MADELINE MCGUIRE | 46d |
| 18287244 | CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR | TCHERKASSKAYA, OLGA V | — |
| 18265217 | MULTISPECIFIC ANTIGEN BINDING PROTEIN | HADDAD, MAHER M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18728162 | PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND | RICCI, CRAIG D | — |
| 18687804 | INHIBITOR OF PROSTATE SPECIFIC MEMBRANE ANTIGEN AND PHARMACEUTICAL USE THEREOF | SAMALA, JAGADISHWAR RAO | — |
| 18287244 | CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR | TCHERKASSKAYA, OLGA V | — |
| 18265217 | MULTISPECIFIC ANTIGEN BINDING PROTEIN | HADDAD, MAHER M | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1615 | 1 |
| 1622 | 1 |
| 1641 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867628 | CRYSTAL FORMS OF TRIAZINE DIONE DERIVATIVE AND PREPARATION METHOD THEREFOR | KOSACK, JOSEPH R | — | §112 | Non-Final OA | — | Pending | Nov 20, 2024 |
| 18728162 | PHARMACEUTICAL COMPOSITION COMPRISING NEUROKININ-1 ANTAGONIST PRODRUG COMPOUND | RICCI, CRAIG D | 1611 | §103§112DP | Non-Final OA | — | Pending | Jul 11, 2024 |
| 18687804 | INHIBITOR OF PROSTATE SPECIFIC MEMBRANE ANTIGEN AND PHARMACEUTICAL USE THEREOF | SAMALA, JAGADISHWAR RAO | — | §112 | Non-Final OA | — | Pending | Feb 28, 2024 |
| 18287244 | CAPSULE FOR SPECIFIC DRUG DELIVERY AND PREPARATION METHOD THEREFOR | TCHERKASSKAYA, OLGA V | 1615 | §103§112 | Non-Final OA | — | Pending | Oct 17, 2023 |
| 18546071 | SMTP-7 DERIVATIVE AND USE THEREOF | DEKARSKE, MADELINE MCGUIRE | 1622 | §103 | Non-Final OA | 46d | Pending | Aug 10, 2023 |
| 18265217 | MULTISPECIFIC ANTIGEN BINDING PROTEIN | HADDAD, MAHER M | 1641 | §102§112 | Final Rejection | — | Pending | Jun 02, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial